DANIEL MUSHER to Microbial Sensitivity Tests
This is a "connection" page, showing publications DANIEL MUSHER has written about Microbial Sensitivity Tests.
Connection Strength
0.822
-
Benefits and costs of rapid drug susceptibility in Staphylococcus aureus bacteremia. Clin Infect Dis. 2011 Apr 15; 52(8):1079; author reply 1079-80.
Score: 0.300
-
Aerococcal infection at three US Tertiary Care Hospitals. South Med J. 2014 Oct; 107(10):642-7.
Score: 0.095
-
Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin. Scand J Infect Dis. 2012 Aug; 44(8):620-2.
Score: 0.081
-
Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results. Infect Control Hosp Epidemiol. 2010 Oct; 31(10):1043-8.
Score: 0.072
-
Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 2006 Sep; 58(3):680-3.
Score: 0.054
-
Antibiotic susceptibilities of genetically characterized Streptococcus milleri group strains. Antimicrob Agents Chemother. 2001 May; 45(5):1511-4.
Score: 0.038
-
Identification of a Klebsiella pneumoniae strain associated with nosocomial urinary tract infection. J Clin Microbiol. 1997 Sep; 35(9):2370-4.
Score: 0.029
-
Antimicrobial activities of beta-lactam antibiotics and gentamicin against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrob Agents Chemother. 1995 May; 39(5):1166-8.
Score: 0.025
-
Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J Infect Dis. 1994 Sep; 170(3):720-3.
Score: 0.024
-
Testing of Streptococcus pneumoniae for resistance to penicillin. J Clin Microbiol. 1993 May; 31(5):1246-50.
Score: 0.022
-
Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis. 2003 Dec 01; 37(11):1405-33.
Score: 0.011
-
Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore). 2003 Sep; 82(5):333-9.
Score: 0.011
-
Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med. 2000 May 22; 160(10):1399-408.
Score: 0.009
-
Treatment of cellulitis with ceforanide. Antimicrob Agents Chemother. 1980 Feb; 17(2):254-7.
Score: 0.009
-
Disk diffusion susceptibility testing of Nocardia species. J Infect Dis. 1977 Apr; 135(4):568-76.
Score: 0.007
-
In vitro antimicrobial effect against Streptococcus pneumoniae of adding rifampin to penicillin, ceftriaxone, or 1-ofloxacin. Antimicrob Agents Chemother. 1995 Dec; 39(12):2798-800.
Score: 0.006
-
Effectiveness of achievable urinary concentrations of tetracyclines against "tetracycline-resistant" pathogenic bacteria. J Infect Dis. 1975 May; 131 Suppl:S40-4.
Score: 0.006
-
Activity of tetracycline, doxycycline, and minocycline against methicillin-susceptible and -resistant staphylococci. Antimicrob Agents Chemother. 1974 Oct; 6(4):411-4.
Score: 0.006
-
Potentiation of the antibacterial effect of methenamine by acetohydroxamic acid. Antimicrob Agents Chemother. 1974 Feb; 5(2):101-5.
Score: 0.006
-
Interaction between acetohydroxamic acid and 12 antibiotics against 14 gram-negative pathogenic bacteria. Antimicrob Agents Chemother. 1974 Feb; 5(2):106-10.
Score: 0.006
-
In vitro activities of streptomycin and 11 oral antimicrobial agents against clinical isolates of Klebsiella rhinoscleromatis. Antimicrob Agents Chemother. 1992 Aug; 36(8):1785-7.
Score: 0.005